摘要
目的:探讨盆腔子宫内膜异位症术后辅以药物治疗的必要性以及术后辅以孕三烯酮、达那唑治疗的临床疗效。方法:选择2008年1月1日～2009年12月31日在我院行腹腔镜保守性手术并经过术后病理证实为盆腔子宫内膜异位症的患者126例,术后辅以药物治疗,其中,孕三烯酮组42例,达那唑组45例,选择同期未行药物治疗的患者39例作为对照组,观察临床症状体征缓解率、复发率及副作用。结果:各用药组的症状和体征缓解率均较对照组明显提高、复发率较对照组降低(均P<0.05)。结论:在保守性手术后加用抑制卵巢功能药物对于提高子宫内膜异位症患者的生活质量具有重要作用。
Objective：To investigate the necessity of pharmacotherapy in the treatment of endometriosis of pelvis after surgery and the effects of gestrinone,danadol on endometriosis after surgery.Methods：A prospective analysis was performed on 126 patients with endometriosis which confirmed by pathologic diagnosis from the 1st January 2008 to the 31st December 2009.All the patients underwent conservative surgery,all the patients were randomly divided into 3 groups：gestrinone group（42 cases）,danadol group （45 cases） and control group（39 cases）.The symptomatic relief rate,side effect,cumulative relapse frequencies were observed and compared.Results：Compared with the control group,the symptomatic relief rate,side effect,relapse rate were obviously increased（all P0.05）.Conclusion：Laparoscopic operation combined with post operative endocrinal therapy has significant importance for decreasing relapse rate and increasing life quality with endometroiosis patients.
出处
《中国医药导报》
CAS
2010年第20期31-33,共3页
China Medical Herald
